EU pharma body welcomes president-elect’s mission letter
11-09-2019
EU committee approves SPC waiver
24-01-2019
EFPIA concerned over SPC waiver amendments
30-11-2018
EFPIA warns that SPC waiver will weaken EU IP framework
18-10-2018
artjazz / iStockphoto.com
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has sharply criticised an opinion on supplementary protection certificate (SPC) proposals that was issued by a European Parliament committee.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
EFPIA, European Parliament, European Parliament Committee on International Trade, International Trade, Health, Pharmaceuticals, SPC manufacturing waiver
